MétaCan
Menu
Back to cohort
Record W4224243429 · doi:10.1016/j.kint.2022.03.019

Genetics in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

2022· article· en· W4224243429 on OpenAlexafffund
Anna Köttgen, Émilie Cornec-Le Gall, Jan Halbritter, Krzysztof Kiryluk, Andrew Mallett, Rulan S. Parekh, Hila Milo Rasouly, Matthew G. Sampson, Adrienne Tin, Corinne Antignac, Elisabet Ars, Carsten Bergmann, Anthony J. Bleyer, Detlef Böckenhauer, Olivier Devuyst, José C. Florez, Kevin Fowler, Nora Franceschini, Masafumi Fukagawa, Daniel P. Gale, Rasheed Gbadegesin, David B. Goldstein, Morgan E. Grams, Anna Greka, Oliver Groß, Lisa M. Guay‐Woodford, Peter C. Harris, Julia Hoefele, Adriana M. Hung, Nine V.A.M. Knoers, Jeffrey B. Kopp, Matthias Kretzler, Matthew B. Lanktree, Beata S. Lipska‐Ziętkiewicz, Kathy Nicholls, Kandai Nozu, Akinlolu Ojo, Afshin Parsa, Cristian Pattaro, York Pei, Martin R. Pollak, Eugene P. Rhee, Simone Sanna‐Cherchi, Judy Savige, John A. Sayer, Francesco Scolari, John R. Sedor, Xueling Sim, Stefan Somlo, Katalin Suszták, Bamidele O. Tayo, Roser Torrá, Albertien M. van Eerde, André Weinstock, Cheryl A. Winkler, Matthias Wuttke, Hong Zhang, Jennifer King, Michael Cheung, Michel Jadoul, Wolfgang C. Winkelmayer­, Ali G. Gharavi

Bibliographic record

VenueKidney International · 2022
Typearticle
Languageen
FieldMedicine
TopicRenal Diseases and Glomerulopathies
Canadian institutionsSt. Joseph’s Healthcare HamiltonHospital for Sick ChildrenPublic Health OntarioMcMaster UniversityWomen's College HospitalSickKids FoundationUniversity of TorontoUniversity Health Network
FundersCanadian Institutes of Health ResearchSanofi GenzymeEuropean Rare Kidney Disease Reference NetworkEuropean Renal Association-European Dialysis and Transplant AssociationAstellas PharmaNovo NordiskAgence Nationale de la RechercheNational Institute on Minority Health and Health DisparitiesDeutsche ForschungsgemeinschaftPfizerBiogenModernaChan Zuckerberg InitiativeAmerican Kidney FundIonis PharmaceuticalsNational Institutes of HealthNateraRegeneron PharmaceuticalsAmicus TherapeuticsUniversity of VirginiaU.S. Department of Veterans AffairsAlexion PharmaceuticalsDaiichi Sankyo EuropeNational Cancer InstituteNierstichtingBayerGilead SciencesAstraZenecaAkebia TherapeuticsBristol-Myers SquibbOno PharmaceuticalEli Lilly and CompanyAlbert-Ludwigs-Universität FreiburgAngionNational Institute of Diabetes and Digestive and Kidney DiseasesSanofiamfAR, The Foundation for AIDS ResearchNational Heart, Lung, and Blood InstituteAcceleron
KeywordsKidney diseaseMedicineDiseaseKidneyIntensive care medicineInternal medicine

Abstract

fetched live from OpenAlex

Numerous genes for monogenic kidney diseases with classical patterns of inheritance, as well as genes for complex kidney diseases that manifest in combination with environmental factors, have been discovered. Genetic findings are increasingly used to inform clinical management of nephropathies, and have led to improved diagnostics, disease surveillance, choice of therapy, and family counseling. All of these steps rely on accurate interpretation of genetic data, which can be outpaced by current rates of data collection. In March of 2021, Kidney Diseases: Improving Global Outcomes (KDIGO) held a Controversies Conference on "Genetics in Chronic Kidney Disease (CKD)" to review the current state of understanding of monogenic and complex (polygenic) kidney diseases, processes for applying genetic findings in clinical medicine, and use of genomics for defining and stratifying CKD. Given the important contribution of genetic variants to CKD, practitioners with CKD patients are advised to "think genetic," which specifically involves obtaining a family history, collecting detailed information on age of CKD onset, performing clinical examination for extrarenal symptoms, and considering genetic testing. To improve the use of genetics in nephrology, meeting participants advised developing an advanced training or subspecialty track for nephrologists, crafting guidelines for testing and treatment, and educating patients, students, and practitioners. Key areas of future research, including clinical interpretation of genome variation, electronic phenotyping, global representation, kidney-specific molecular data, polygenic scores, translational epidemiology, and open data resources, were also identified.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.032
metaresearch head score (Gemma)0.039
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Review · Consensus signal: none
Teacher disagreement score0.032
Threshold uncertainty score0.167

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0320.039
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0030.004
Bibliometrics0.0040.003
Science and technology studies0.0020.003
Scholarly communication0.0060.009
Open science0.0030.006
Research integrity0.0130.030
Insufficient payload (model declined to judge)0.0060.003

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.013
GPT teacher head0.283
Teacher spread0.271 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations187
Published2022
Admission routes2
Has abstractyes

Explore more

Same venueKidney InternationalSame topicRenal Diseases and GlomerulopathiesFrench-language works237,207